Clinical Trials Sponsored by Hospitales Nisa

Total 108989 results

National Institute on Drug Abuse (NIDA)

Completed

Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Integrated Treatment for Cocaine and Mood Disorders - 1

Depressive Disorder, Major | Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Substance Dependent Teens - Impact of Treating Depression Study 1 - 1

Substance-Related Disorders | Alcohol-Related Disorders | Marijuana Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Bupropion as an Adjunct to the Nicotine Patch Plus CBT

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Terminated

Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Cognitive Correlates of Substance Abuse, Part 2 - 16

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1

Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Multi-Level HIV Prevention for Pregnant Drug Abusers (PDA)

Substance Related Disorders
National Institute on Drug Abuse (NIDA)

Unknown

Effects of Stimulant Dependence on Human Striatal Dopamine System - 15

Tobacco Use Disorder | Amphetamine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Unknown

Infusion Laboratory: Protocol 5 (Flupenthixol) - 14

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers (CASA)

Drug Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Preventing Substance Use and Risky Behavior Among Rural African American Youth

Risky Sexual Behavior

United States
National Institute on Drug Abuse (NIDA)

Unknown

Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1

Cocaine-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Drug Use Prevention Among Girls Through a Mother-Daughter Intervention

Adolescent Behavior

United States
National Institute on Drug Abuse (NIDA)

Unknown

Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1

Cocaine-Related Disorders | Drug Administration Schedule | Infusions, Intravenous

United States
National Institute on Drug Abuse (NIDA)

Unknown

Implementing Tobacco Control in Dental Practice

Smoking

United States
National Institute on Drug Abuse (NIDA)

Unknown

A Behavioral Trial for the Treatment of Methamphetamine Dependence. - 1

Substance-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Using Tobacco Free Snuff in Reducing Negative Effects of Smokeless Tobacco Use

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

A Survey on Consumer Use of Over-the-Counter (OTC) Nicotine Patches

Tobacco Use Disorder | Nicotine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2

Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Smoking Cessation | Tobacco Use Disorder

United States
National Institute on Drug Abuse (NIDA)

Completed

Reduction of Smoking in Cardiac Disease Patients

Cardiovascular Disease | Tobacco Use Disorder

United States
National Aeronautics and Space Administration (NASA)

Completed

Dietary Intake Modifications to Protect Against Changes in Bone Metabolism (ProK)

Bone Resorption

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
Brown University
National Institute on Drug Abuse (NIDA); The Miriam Hospital

Recruiting

Open Trial to Improve Retention in Care for Persons With HIV Who Use Substances

Hiv | Substance Use Disorders

United States
Denver Health and Hospital Authority
National Institute on Drug Abuse (NIDA)

Active, not recruiting

The DETECT HCV Linkage to Care Trial (DETECT HCV)

Hepatitis C

United States
Massachusetts General Hospital
National Institute on Aging (NIA); Brigham and Women's Hospital

Completed

Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women

Hot Flashes | Menopause | Vasomotor Disturbance

United States
Brown University
National Institute on Drug Abuse (NIDA); The Miriam Hospital; Rhode Island Hospital

Recruiting

Open Label Placebo to Reduce Prescription Opioid Use

Acute Pain

United States
SymTrend Inc.
Massachusetts General Hospital; National Institute on Aging (NIA)

Unknown

Managing Vascular Dementia Risk Factors With SymTrend

Vascular Dementia

United States
University Hospital, Brest
University of Lausanne Hospitals; Fondation Paralysie Cérébrale; Université Catholique... and other collaborators

Completed

Evaluation of Functional, Neuroplastic and Biomechanical Changes Induced by an Intensive, Playful Early-morning Treatment Including Lower Limbs (EARLY-HABIT-ILE) in Preschool Children With Uni and Bilateral Cerebral Palsy (HABIT-ILE)

Cerebral Palsy

France
The Methodist Hospital Research Institute
National Institute on Aging (NIA)

Enrolling by invitation

Feasibility and Acceptability of ReCognitionVR-based Cognitive Stimulation in Surgical Patients

Delirium | Surgery | Delirium, Post-Operative

United States
National Institute on Aging (NIA)
Spaulding Rehabilitation Hospital PM&R

Completed

A Comparison of Weighted Vest Exercise and Strength Training

Aging | Mobility Limitations

United States
Regeneron Pharmaceuticals
ISA Pharmaceuticals B.V.

Active, not recruiting

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

Cervical Cancer

Spain, Korea, Republic of, Netherlands, Brazil, Belgium, United States, Italy, Russian Federation
National Institute on Aging (NIA)

Completed

Serum, Dietary and Supplemental Vitamin D's Association With Cognitive Decline

Cognitive Impairment | Cognitive Decline

United States
National Institute on Aging (NIA)

Completed

Vitamin D-related Genes and Metabolic Disorders

Obesity | Metabolic Syndrome | Central Obesity
National Institute on Aging (NIA)

Terminated

Osteoarthritis and Body Composition: Evaluation of Systematic Mediators

Knee Osteoarthritis

United States
National Institute on Aging (NIA)

Unknown

Evolution of Memory Related Activity

Mild Cognitive Impairment | Alzheimer's Disease

United States
National Institute on Aging (NIA)

Unknown

Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia

Down Syndrome | Alzheimer's Disease

United States
National Institute on Aging (NIA)

Unknown

Implications of Amyloid Pathology

Alzheimer's Disease

United States
National Institute on Aging (NIA)

Unknown

Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome

Down Syndrome | Alzheimer's Disease

United States
National Institute on Aging (NIA)

Unknown

Predictors of Cognitive Decline in Normal Aging

Dementia | Alzheimer Disease

United States
National Institute on Aging (NIA)

Completed

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Parkinson Disease | Dementia

United States
National Institute on Aging (NIA)

Completed

Obesity Prevention After Smoking Cessation in Menopause

Obesity | Menopause

United States

Clinical Trials Sponsored by Hospitales Nisa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahamas

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations